137 related articles for article (PubMed ID: 18464803)
1. Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis.
Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
Eye (Lond); 2009 Apr; 23(4):910-4. PubMed ID: 18464803
[TBL] [Abstract][Full Text] [Related]
2. Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis.
Roesel M; Tappeiner C; Heinz C; Koch JM; Heiligenhaus A
Am J Ophthalmol; 2009 Mar; 147(3):406-12. PubMed ID: 19054496
[TBL] [Abstract][Full Text] [Related]
3. [Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis].
Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
Klin Monbl Augenheilkd; 2009 Feb; 226(2):110-4. PubMed ID: 19206044
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546
[TBL] [Abstract][Full Text] [Related]
5. Low-dose intraocular triamcinolone injection for intractable macular oedema and inflammation in patients with uveitis.
Das-Bhaumik RG; Jones NP
Eye (Lond); 2006 Aug; 20(8):934-7. PubMed ID: 16096656
[TBL] [Abstract][Full Text] [Related]
6. [Macular oedema and intravitreal triamcinolone injections].
Gunnlaugsdóttir E; Oehman DO; Gunnarsdóttir SG; Stefánsson E
Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome.
Angunawela RI; Heatley CJ; Williamson TH; Spalton DJ; Graham EM; Antcliffe RJ; Stanford MR
Acta Ophthalmol Scand; 2005 Oct; 83(5):595-9. PubMed ID: 16187999
[TBL] [Abstract][Full Text] [Related]
9. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
10. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
11. Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis.
Roesel M; Heinz C; Koch JM; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):715-20. PubMed ID: 20082200
[TBL] [Abstract][Full Text] [Related]
12. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
14. The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.
van Kooij B; Rothova A; de Vries P
Ocul Immunol Inflamm; 2006 Apr; 14(2):73-85. PubMed ID: 16597536
[TBL] [Abstract][Full Text] [Related]
15. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
16. [Intravitreal injection of triamcinolone acetonide in non infectious uveitis].
Benítez Del Castillo Sánchez JM; García Sánchez J
Arch Soc Esp Oftalmol; 2001 Nov; 76(11):661-4. PubMed ID: 11715104
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema.
Bakri SJ; Shah A; Falk NS; Beer PM
Eye (Lond); 2005 Jun; 19(6):686-8. PubMed ID: 15332099
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
Morrison VL; Kozak I; LaBree LD; Azen SP; Kayicioglu OO; Freeman WR
Ophthalmology; 2007 Feb; 114(2):334-9. PubMed ID: 17270681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
